Department of Pathology

Medicine & Life Sciences

1. Neoplasms 100%
2. Lymphoma, Large B-Cell, Diffuse 65%
3. Carcinoma 65%
4. Monocrotaline 62%
5. Human Herpesvirus 4 60%
6. Lung 57%
7. Non-Small Cell Lung Carcinoma 53%
8. Breast Neoplasms 49%
9. Adenocarcinoma of Lung 47%
10. Urinary Bladder 45%
11. T-Cell Lymphoma 44%
12. Lymphoma 43%
13. Mutation 43%
14. Lymph Nodes 42%
15. Adenocarcinoma 41%
16. Neoplasm Metastasis 41%
17. Biopsy 40%
18. Pulmonary Hypertension 36%
19. Tomography 36%
20. Stomach 35%
21. Triple Negative Breast Neoplasms 34%
22. T-Lymphocytes 32%
23. Survival 31%
24. Peripheral T-Cell Lymphoma 29%
25. Marginal Zone B-Cell Lymphoma 29%
26. Pathology 29%
27. Paraganglioma 28%
28. Lymphoproliferative Disorders 27%
29. B-Cell Lymphoma 27%
30. Colorectal Neoplasms 27%
31. Stomach Neoplasms 26%
32. Recurrence 26%
33. Regulatory T-Lymphocytes 26%
34. Liver 25%
35. Lymphocytes 25%
36. Breast 25%
37. Therapeutics 24%
38. erbB-1 Genes 24%
39. Immunohistochemistry 24%
40. Mucous Membrane 24%
41. Lung Neoplasms 24%
42. Staining and Labeling 24%
43. Drug Therapy 23%
44. Natural Killer T-Cells 23%
45. Gene Expression 22%
46. Vascular Endothelial Growth Factor A 22%
47. Natural Killer Cells 22%
48. Endothelin A Receptors 22%
49. Genes 22%
50. Kidney 22%
51. Cell Biology 21%
52. Non-Hodgkin's Lymphoma 21%
53. ErbB Receptors 21%
54. Extranodal NK-T-Cell Lymphoma 20%
55. Rituximab 20%
56. Histology 20%
57. Ductal Carcinoma 19%
58. Proteins 19%
59. Acute Lung Injury 19%
60. Mesenchymal Stem Cells 19%
61. Androgen Receptors 18%
62. Anaplastic Lymphoma Kinase 18%
63. Urinary Bladder Neoplasms 18%
64. Nose 18%
65. Anaplastic Large-Cell Lymphoma 18%
66. Anthracyclines 18%
67. Hydroa Vacciniforme 18%
68. Tumor-Infiltrating Lymphocytes 17%
69. Bleomycin 17%
70. Gallbladder 17%
71. Helicobacter pylori 17%
72. Disease-Free Survival 17%
73. Squamous Cell Carcinoma 16%
74. Epstein-Barr Virus Infections 16%
75. Uterine Cervical Neoplasms 16%
76. Glioblastoma 16%
77. Fibrosis 16%
78. Cardiotoxicity 16%
79. Collagen 15%
80. Doxorubicin 15%
81. Astrocytoma 15%
82. Neuroendocrine Carcinoma 15%
83. Endothelin Receptors 15%
84. Apoptosis 15%
85. Endometrioid Carcinoma 15%
86. Papillary Carcinoma 15%
87. Hepatocyte Growth Factor 15%
88. DNA 14%
89. Colonic Neoplasms 14%
90. Duodenum 14%
91. Frozen Sections 14%
92. Inflammation 14%
93. Interleukin-6 14%
94. Prostate 14%
95. B-Lymphocytes 13%
96. Human Papillomavirus DNA Tests 13%
97. Tumor Necrosis Factor-alpha 13%
98. Renal Cell Carcinoma 13%
99. Multicenter Studies 13%
100. Fluorodeoxyglucose F18 13%